A CRIMEAN-CONGO HAEMORRHAGIC FEVER OUTBREAK IN NORTHERN BALOCHISTAN

被引:0
|
作者
Ali, Nadir [1 ]
Chotani, Rashid A. [2 ,3 ,4 ]
Anwar, Masood [5 ]
Nadeem, Mansoor [1 ]
Karamat, Karamat Ahmed [6 ]
Tariq, Waheed Uz Zaman [5 ]
机构
[1] CMH, Dept Pathol, Karachi, Pakistan
[2] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[3] Johns Hopkins Bloomburg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[4] Johns Hopkins Sch Med & Publ Hlth, Baltimore, MD USA
[5] Army Med Coll, Dept Pathol, Rawalpindi, Pakistan
[6] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan
关键词
Crimean-Congo hemorrhagic fever (CCHF); Endemic; Anti-viral; Oral Ribavirin; Clinical management; Gastrointestinal hemorrhage;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe the clinical characteristics, epidemiology, predictors of fatal outcome (PFO), and management effects of Crimean-Congo haemorrhagic fever (CCHF) patients during an outbreak in Northern Balochistan. Design: Descriptive study. Place and Duration of Study: Fatima Jinnah Hospital and Combined Military Hospital, Quetta, from June to October, 2001. Patients and Methods: Patients presenting with a fever of less than 2 weeks duration and bleeding manifestations were included. Clinical history was recorded and patients were placed on oral ribavirin, and hematological support. Diagnosis was established by PCR for CCHF or detection of CCHF specific IgM and IgG. Results: Eighty-four patients were received, 34 (40.5%) were suspected of suffering from classical CCHF. All 34 (100%) patients presented with a history of fever and bleeding (epistaxis, gum bleeding, melena or haematuria). Mean platelet count was 30 x 10(9)/L and mean ALT (alanine transferase) was 288 U/L. Among fatal cases, the mean platelet count was 18.4 x 10(9)/L and ALT was 781 units/L. PCR for CCHF viral RNA performed on 10 patients was positive in 3 (30%) patients. CCHF specific IgM and IgG was positive in 17.6% (6/34). Four patients were brought in moribund condition and expired before treatment could be started, 4 patients expired during treatment and 76.5% (26/34) were cured. The overall mortality was 23.5% (8/34). Main predictors of fatal outcome were ALT >= 150 units/L, activated partial thromboplastin time(aPT) >= 60 seconds, prothrombin time (PT) >= 34 seconds, aspartate transferase (AST) >= 200 units/L, platelets <= 20 x 10(9)/L, and fibrinogen <= 110 mg/dL. Conclusion: In this series of CCHF occurring in Northern parts of Balochistan, gastrointestinal tract bleeding was the worst prognostic factor associated with fatal outcome. Providing education to healthcare workers and at risk populations, hematological support, anti-viral drugs, and barrier nursing may help reduce mortality.
引用
收藏
页码:477 / 481
页数:5
相关论文
共 50 条
  • [31] Epidemiological investigations of Crimean-Congo haemorrhagic fever virus infection in sheep and goats in Balochistan, Pakistan
    Kasi, Khushal Khan
    Sas, Miriam Andrada
    Sauter-Louis, Carola
    von Arnim, Felicitas
    Gethmann, Joern Martin
    Schulz, Ansgar
    Wernike, Kerstin
    Groschup, Martin H.
    Conraths, Franz J.
    TICKS AND TICK-BORNE DISEASES, 2020, 11 (02)
  • [32] The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey
    Koksal, I.
    Yilmaz, G.
    Aksoy, F.
    Erensoy, S.
    Aydin, H.
    EPIDEMIOLOGY AND INFECTION, 2014, 142 (02): : 239 - 245
  • [33] A Q fever case mimicking Crimean-Congo haemorrhagic fever
    Karabay, O.
    Gozdas, H. T.
    Ozturk, G.
    Tuna, N.
    Utku, A. C.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 29 (04) : 418 - 419
  • [34] Emerging Threat: Crimean-Congo Hemorrhagic Fever in Balochistan, Pakistan
    Hussain, Syed Ahmed Shahzaeem
    Irfan, Hamza
    Ali, Mohammad Haris
    Talha, Muhammad
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2024, 36 (2-3) : 268 - 269
  • [35] Crimean-Congo haemorrhagic fever: "What is not sought is not found"
    Oteo, Jose A.
    Palomar, Ana M.
    MEDICINA CLINICA, 2018, 150 (07): : 266 - 267
  • [36] Crimean-Congo Haemorrhagic Fever: Breaking the chain of transmission
    Shaikh, Muhammad Ateeb
    Safder, Sahar
    Bhatty, Shaheen Ayoob
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2015, 65 (05) : 576 - 576
  • [37] Laboratory criteria for severe Crimean-Congo haemorrhagic fever
    Ortatatli, Mesut
    Sarici, Serdar Umit
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (02) : 365 - 366
  • [38] Crimean-Congo Haemorrhagic Fever and the Role of the Migrating Birds
    Kepenek-Kurt, Esma
    Kandemir, Bahar
    Erayman, Ibrahim
    Bulut, Rukiyye
    Bitirgen, Mehmet
    KLIMIK JOURNAL, 2019, 32 (03) : 292 - 297
  • [39] Seroprevalance of Crimean-Congo haemorrhagic fever in Bulgarian livestock
    Barthel, Robert
    Mohareb, Emad
    Younan, Rasha
    Gladnishka, Teodora
    Kalvatchev, Nikolay
    Moemen, Abdel
    Mansour, Sameh S.
    Rossi, Cynthia
    Schoepp, Randal
    Christova, Iva
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2014, 28 (03) : 540 - 542
  • [40] Crimean-Congo haemorrhagic fever: test early with ROTEM?
    Scarlatescu, Ecaterina
    Lance, Marcus D.
    LANCET INFECTIOUS DISEASES, 2019, 19 (08): : 796 - 797